Medicare Enrolled

Dr. Kris Gaston, MD

Urology Physician · Charlotte, NC
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
1021 MOREHEAD MEDICAL DR, Charlotte, NC 28204
9804422000
In practice since 2006 (20 years)
NPI: 1881657252 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Gaston from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gaston? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Gaston

Dr. Kris Gaston is an urology physician in Charlotte, NC, with 20 years of NPI registration. Based on federal Medicare data, Dr. Gaston performed 1,860 Medicare services across 316 unique beneficiaries.

Between the years covered by Open Payments, Dr. Gaston received a total of $4,082 from 28 pharmaceutical and/or device companies across 68 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Gaston is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 40% volume in NC $4,082 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,860
Medicare services
Top 40% in NC for urology physician
316
Unique beneficiaries
$22
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~93 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
BCG treatment for bladder cancer 1,500 $2 $10
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
129 $91 $344
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
63 $112 $533
Urinalysis, manual
A manual laboratory examination of a urine sample to check for various substances and cells.
47 $3 $18
Bladder instillation of anti-cancer drug
A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue.
32 $71 $468
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
25 $39 $140
Cystourethroscopy
A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract.
22 $184 $837
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
19 $122 $464
Office visit for established patient
An office visit for an existing patient that may not require the healthcare professional to be present.
12 $18 $75
Surgical removal of prostate and lymph nodes
This procedure involves the surgical removal of the prostate gland and surrounding lymph nodes using an endoscope.
11 $860 $7,242
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$4,082
Total received (2018-2024)
Avg $680/year across 6 years
Top 36% in NC for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
28
Companies
68
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,082 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,024
2023
$1,041
2022
$849
2021
$507
2019
$229
2018
$433

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Ethicon US, LLC
$315
IMMUNITYBIO, INC.
$150
UROGEN PHARMA, INC.
$144
Astellas Pharma Global Development
$104
Blue Earth Diagnostics Limited
$100
Medtronic, Inc.
$78
Olympus America Inc.
$51
PFIZER INC.
$43
Innovation Technologies Inc
$25
COLOPLAST CORP
$14
Top 3 companies account for 59.5% of 2024 payments
All-time payments by company (2018-2024) ›
Ethicon US, LLC
$867
Biom'Up France SAS
$360
Intuitive Surgical, Inc.
$201
Medtronic, Inc.
$195
Dilon Technologies, Inc.
$179
Novartis Pharmaceuticals Corporation
$161
DAVOL INC.
$161
Dendreon Pharmaceuticals LLC
$160
IMMUNITYBIO, INC.
$150
UROGEN PHARMA, INC.
$144
AngioDynamics, Inc.
$143
NeoTract Inc.
$141
Kerecis Limited
$136
Astellas Pharma US Inc
$129
Foundation Medicine, Inc.
$127
AstraZeneca Pharmaceuticals LP
$107
Astellas Pharma Global Development
$104
Blue Earth Diagnostics Limited
$100
PFIZER INC.
$96
EMD Serono, Inc.
$95
Boston Scientific Corporation
$85
BOSTON SCIENTIFIC CORPORATION
$82
Olympus America Inc.
$51
ConvaTec Inc.
$38
Innovation Technologies Inc
$25
Coloplast Corp
$17
180 Medical, Inc.
$16
COLOPLAST CORP
$14
Top 3 companies account for 35.0% of all-time payments
Associated products mentioned in payments ›
ANKTIVA · ARISTA AH · BAVENCIO · DERMABOND · Da Vinci Surgical System · ECHELON ENDOPATH · ETHICON · EVICEL Fibrin Sealant (Human) · Echelon Flex · Echelon; Endopath · Enseal X1 · Enseal X1 5mm · FOUNDATIONONE · GENERAL BPH · GENTLECATH · GENTLECATH GLIDE · HEMOBLAST BELLOWS · INTERSTIM · IRRISEPT · JELMYTO · Kerecis Omega3 SurgiClose · LithoVue · NANOKNIFE · PERCUFLEX · PLUVICTO · POSLUMA · PROGEL · PROVENGE · STRATAFIX · SURGIFLO Hemostatic Matrix · Titan · UroLift · VISTASEAL · XTANDI · Xtandi · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an urology physician in Charlotte?
Compare urology physicians in the Charlotte area by procedure volume, costs, and industry payment transparency.
Browse urology physicians nearby

Geographic Context

Urology physicians within 10 mi
81
Per 100K population
7.2
County median income
$83,765
Nearest hospital
CAROLINAS MEDICAL CENTER/BEHAV HEALTH
1.8 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Gaston is a mixed practice specialist, with moderate Medicare volume, with low-engagement industry engagement, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Gaston experienced with bcg treatment for bladder cancer?
Based on Medicare claims data, Dr. Gaston performed 1,500 bcg treatment for bladder cancer services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Gaston receive payments from pharmaceutical companies?
Yes. Dr. Gaston received a total of $4,082 from 28 companies across 68 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gaston's costs compare to other urology physicians in Charlotte?
Dr. Gaston's average Medicare payment per service is $22. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gaston) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →